Metoprolol IV Mylan
Metoprolol tartrate injection
Consumer Medicine Information
What is in this leaflet
This leaflet answers some of the common questions people ask about Metoprolol IV Mylan. It does not contain all the information that is known about Metoprolol IV Mylan.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor will have weighed the risks of your being given Metoprolol IV Mylan against the benefits they expect it will have for you.
If you have any concerns about being given this medicine, ask your doctor, nurse or pharmacist.
Keep this leaflet with the medicine. You may need to read it again.
What Metoprolol IV Mylan is used for
Metoprolol Tartrate belongs to a group of medicines called beta-blockers.
Metoprolol Tartrate is used to treat irregular heartbeat, also known as arrhythmia, which means that there is a disturbance of the heart's normal rhythm or beat.
Arrhythmias may be caused by a number of factors, including some heart diseases, an overactive thyroid gland, or chemical imbalances. Also, after a heart attack there is a chance of developing arrhythmias.
Metoprolol Tartrate helps to restore your heart beat to a more normal rate, particularly if it is beating very fast.
Your doctor may have prescribed this medicine for another reason.
Your doctor will have explained why you are being treated with Metoprolol Tartrate and told you what dose you will be given.
Follow all directions given to you by your doctor carefully. They may differ from the information contained in this leaflet.
Ask your doctor if you have any questions about why Metoprolol IV Mylan has been prescribed for you.
Metoprolol Tartrate is not addictive.
Before you are given Metoprolol IV Mylan
When you must not be given it
Do not take Metoprolol IV Mylan if:
- you are pregnant or intend to become pregnant
Metoprolol Tartrate may affect your baby if you are given it early in pregnancy or in the last weeks before your baby is due.
- you are breast-feeding or plan to breast-feed
Metoprolol Tartrate passes into breast milk and therefore there is a possibility that the breast-fed baby may be affected.
Metoprolol IV Mylan should not be used if the expiry date (EXP) printed on the pack has passed. It may have no effect at all, or worse, an entirely unexpected effect if it is used after the expiry date.
Do not use Metoprolol IV Mylan if the packaging is torn or shows signs of tampering.
Do not give Metoprolol IV Mylan to children. The safety and effectiveness of Metoprolol Tartrate in children has not been established.
Before you are given it
Tell your doctor if:
- you have any allergies to:
- Metoprolol Tartrate or any of the ingredients listed at the end of this leaflet.
- any other medicine or other beta-blocker medicines
- any other substances, such as foods, preservatives or dyes.
- you have or have had any medical conditions, especially the following:
- an overactive thyroid gland
- liver problems
- kidney problems
- certain types of angina
- any other heart problems
If you have not told your doctor about any of the above, tell them before you are given Metoprolol IV Mylan.
Taking other medicines
Tell your doctor or pharmacist if you are taking any other medicines, including:
- other beta-blocker medicines, including beta-blocker eye drops
- medicines used to treat high blood pressure or angina
- medicines used to treat heart problems
- insulin and tablets used to treat diabetes
- medicines used to treat depression
- medicines that you buy without a prescription at the chemist, supermarket or health food shop.
These medicines may be affected by Metoprolol Tartrate or may affect how well it works.
You may need to be given different amounts of your medicine, or you may need to be given different medicines. Your doctor will advise you.
Your doctor has more information on medicines to be careful with or avoid while using Metoprolol IV Mylan.
How Metoprolol IV Mylan is given
Metoprolol IV Mylan is given as a slow injection into a vein.
Metoprolol IV Mylan must only be given by a doctor or nurse.
Your doctor will decide what dose and for how long you will receive Metoprolol Tartrate. This depends on your condition and other factors, such as your weight.
To begin treatment, up to 5 mg of Metoprolol Tartrate is given at a rate of 1 to 2 mg per minute. This dose may be repeated at 5-minute intervals until a satisfactory effect is achieved.
Your blood pressure and ECG will be monitored during the treatment.
If you are given too much
The doctor giving you Metoprolol Tartrate will be experienced in its use, so it is unlikely that you will be given an overdose.
However, if you are accidentally given an overdose of Metoprolol Tartrate you may have nausea, vomiting, convulsions, extreme slowing of the heartbeat, lowered blood pressure, possible heart failure and breathing difficulties. In extreme cases, your skin may turn blue, and you may get shock, unconsciousness or coma. Your doctor has information on how to recognise and treat an overdose. Ask your doctor if you have any concerns.
Tell your doctor as soon as possible if you do not feel well while you are being given Metoprolol IV Mylan. Metoprolol Tartrate helps most people with irregular heartbeat, but it may have unwanted side effects in a few people.
If you are over 65 years of age you may have an increased chance of getting side effects.
All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.
Ask your doctor to answer any questions you may have.
Tell your doctor or nurse if you notice any of the following and they worry you:
- swelling, burning sensation, changes in skin colour or texture where you had the injection
- swelling or pain in a vein
- headache, tiredness, drowsiness
- aches and pains, painful joints
- nausea (feeling sick), vomiting
- weakness, lack of energy
- stomach upset, diarrhoea or constipation
- dry mouth, changes in taste sensation
- difficulty sleeping, nightmares
- mood changes
- confusion, short-term memory loss, inability to concentrate
- increased sweating, runny or blocked nose
- hair loss
- weight gain.
These side effects are usually mild.
Tell your doctor or nurse immediately if you notice any of the following:
- dizziness, light-headedness or fainting especially on standing up
- tingling or "pins and needles"
- skin rash or worsening of psoriasis
- symptoms of sunburn happening more quickly than before
- abnormal thinking or hallucinations
- buzzing or ringing in the ears, deafness
- irritated eyes or blurred vision
- sexual problems.
These are serious side effects. You may need urgent medical attention. Serious side effects are rare.
If any of the following happen, tell your doctor or nurse immediately:
- shortness of breath, being less able to exercise
- swelling of the ankles, feet or legs
- chest tightness, wheezing, noisy breathing
- chest pain, changes in heart rate or palpitations
- swelling of the face, lips, tongue or throat
- yellowing of the skin or eyes (jaundice), generally feeling unwell
- constant "flu-like" symptoms with tiredness or lack of energy.
These are very serious side effects. You may need urgent medical attention or hospitalisation. These side effects are rare.
Some people may get other side effects while being given Metoprolol Tartrate.
Do not be alarmed by this list of possible side effects. You may not experience any of them.
After being given Metoprolol IV Mylan
Metoprolol IV Mylan will be stored in the pharmacy ward.
The injection is kept in a cool, dry place, protected from light, where the temperature stays below 25°C.
What Metoprolol IV Mylan looks like
Metoprolol IV Mylan is a clear liquid packaged in 5 mL glass vials containing the active ingredient, Metoprolol tartrate, in packs of 5 vials.
Each vial of Metoprolol IV Mylan contains 5 mg of metoprolol tartrate. The vials also contain sodium chloride and water for injections.
Alphapharm Pty Limited
(ABN 93 002 359 739)
Level 1, 30 The Bond
30-34 Hickson Road
Millers Point NSW 2000
Phone: (02) 9298 3999
Australian Registration Number:
AUST R 204665
This leaflet was prepared in March 2015.
Metoprolol IV Mylan_cmi/Mar15/00
Published by MIMS August 2015